Skip to main content
Lakshmi Bhagat

Lakshmi Bhagat

Associate Scientific Director, Luye Pharma Group
Lakshmi is currently leading the oligonucleotide group as an Associate Director at GeneLeap Biotechnology. She holds a PhD from University of Delhi, India and did her postdoctoral training from Massey University, New Zealand, and Harvard Medical School. She has more than 20 years of experience in the drug development industry with expertise in nucleic acid therapeutics including innate immune receptor agonists and antagonists, antisense and siRNA. She was involved in the development of Idera Pharmaceuticals’s TLR9 agonist, Tilsotolimod from discovery to Phase 3 clinical trial. Lakshmi is a co-inventor of 33 US patents and a co-author of 50+ peer-reviewed publications.